Persistent Cutaneous T-Cell Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB02546 | Vorinostat | A histone deacetylase (HDAC) inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. |
Drug | Drug Name | Phase | Status | Count |
---|